Pub Date : 2003-06-01DOI: 10.1016/S1477-3627(03)02316-X
Daniel Auerbach , Michael Fetchko , Igor Stagljar
The availability of complete genome sequences of numerous model organisms has initiated the development of new approaches in biological research to complement conventional biochemistry and genetics. In this context, high-throughput methods for detecting protein interactions, such as mass spectrometry and yeast two-hybrid assays, have produced vast amounts of data that can be exploited to infer protein function and regulation. In this review, we explore different genome-wide protein interaction studies and comment on their extrapolation towards understanding protein functions. It is likely that improvements of these approaches, together with more sophisticated databases and the invention of novel technologies, will help to decipher the complex interactions among proteins and to integrate interacting proteins into existing and novel cellular pathways.
{"title":"Proteomic approaches for generating comprehensive protein interaction maps","authors":"Daniel Auerbach , Michael Fetchko , Igor Stagljar","doi":"10.1016/S1477-3627(03)02316-X","DOIUrl":"10.1016/S1477-3627(03)02316-X","url":null,"abstract":"<div><p>The availability of complete genome sequences of numerous model organisms has initiated the development of new approaches in biological research to complement conventional biochemistry and genetics. In this context, high-throughput methods for detecting protein interactions, such as mass spectrometry and yeast two-hybrid assays, have produced vast amounts of data that can be exploited to infer protein function and regulation. In this review, we explore different genome-wide protein interaction studies and comment on their extrapolation towards understanding protein functions. It is likely that improvements of these approaches, together with more sophisticated databases and the invention of novel technologies, will help to decipher the complex interactions among proteins and to integrate interacting proteins into existing and novel cellular pathways.</p></div>","PeriodicalId":101208,"journal":{"name":"TARGETS","volume":"2 3","pages":"Pages 85-92"},"PeriodicalIF":0.0,"publicationDate":"2003-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1477-3627(03)02316-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86752315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2003-06-01DOI: 10.1016/S1477-3627(03)02310-9
Timothy J. Egan
Historically, chloroquine has been the most important antimalarial. Current evidence suggests that resistance to this drug is not the result of a change in its target, which remains important in the design of novel antimalarials, an area of active research. Many studies support the hypothesis that this target is haematin, whereas a recent report suggests that the haemozoin (malaria pigment) crystal itself might in fact be the target. A detailed understanding of the mechanism and structure of this interaction could revolutionise the search for new antimalarials in the near future.
{"title":"Haemozoin (malaria pigment): a unique crystalline drug target","authors":"Timothy J. Egan","doi":"10.1016/S1477-3627(03)02310-9","DOIUrl":"10.1016/S1477-3627(03)02310-9","url":null,"abstract":"<div><p>Historically, chloroquine has been the most important antimalarial. Current evidence suggests that resistance to this drug is not the result of a change in its target, which remains important in the design of novel antimalarials, an area of active research. Many studies support the hypothesis that this target is haematin, whereas a recent report suggests that the haemozoin (malaria pigment) crystal itself might in fact be the target. A detailed understanding of the mechanism and structure of this interaction could revolutionise the search for new antimalarials in the near future.</p></div>","PeriodicalId":101208,"journal":{"name":"TARGETS","volume":"2 3","pages":"Pages 115-124"},"PeriodicalIF":0.0,"publicationDate":"2003-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1477-3627(03)02310-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73034692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2003-04-01DOI: 10.1016/S1477-3627(03)02299-2
Jürgen Bajorath
{"title":"Jürgen Bajorath discusses integrating disciplines in the drug discovery industry","authors":"Jürgen Bajorath","doi":"10.1016/S1477-3627(03)02299-2","DOIUrl":"https://doi.org/10.1016/S1477-3627(03)02299-2","url":null,"abstract":"","PeriodicalId":101208,"journal":{"name":"TARGETS","volume":"2 2","pages":"Pages 45-47"},"PeriodicalIF":0.0,"publicationDate":"2003-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1477-3627(03)02299-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89988680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2003-04-01DOI: 10.1016/S1477-3627(03)02296-7
Thomas S. May (freelance writer)
{"title":"New high-throughput NMR","authors":"Thomas S. May (freelance writer)","doi":"10.1016/S1477-3627(03)02296-7","DOIUrl":"10.1016/S1477-3627(03)02296-7","url":null,"abstract":"","PeriodicalId":101208,"journal":{"name":"TARGETS","volume":"2 2","pages":"Pages 39-40"},"PeriodicalIF":0.0,"publicationDate":"2003-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1477-3627(03)02296-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76243807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2003-04-01DOI: 10.1016/S1477-3627(03)02297-9
Vida Foubister (freelance writer)
{"title":"Nematode model for obesity","authors":"Vida Foubister (freelance writer)","doi":"10.1016/S1477-3627(03)02297-9","DOIUrl":"https://doi.org/10.1016/S1477-3627(03)02297-9","url":null,"abstract":"","PeriodicalId":101208,"journal":{"name":"TARGETS","volume":"2 2","pages":"Pages 40-41"},"PeriodicalIF":0.0,"publicationDate":"2003-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1477-3627(03)02297-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91634014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2003-04-01DOI: 10.1016/S1477-3627(03)02298-0
Robert A. Coleman, Kenneth L. Clark
Arguably, one of the main reasons for the pharmaceutical industry's current poor performance in bringing successful new drugs to market is its over-reliance on animal data in the discovery and development processes. We propose that more use should be made of donated human tissues in order to identify and validate drug targets and to discover and develop novel drugs to act upon them. We review the ways that human tissues may be used for this purpose, from the measurement of gene expression, through determination of specific protein abundance, to functional evaluation, both at the level of tissue and specific cell type. The proposal is not simply theoretical, as we provide a specific case history to illustrate these points.
{"title":"Target validation using human tissue: from gene expression to function","authors":"Robert A. Coleman, Kenneth L. Clark","doi":"10.1016/S1477-3627(03)02298-0","DOIUrl":"https://doi.org/10.1016/S1477-3627(03)02298-0","url":null,"abstract":"<div><p>Arguably, one of the main reasons for the pharmaceutical industry's current poor performance in bringing successful new drugs to market is its over-reliance on animal data in the discovery and development processes. We propose that more use should be made of donated human tissues in order to identify and validate drug targets and to discover and develop novel drugs to act upon them. We review the ways that human tissues may be used for this purpose, from the measurement of gene expression, through determination of specific protein abundance, to functional evaluation, both at the level of tissue and specific cell type. The proposal is not simply theoretical, as we provide a specific case history to illustrate these points.</p></div>","PeriodicalId":101208,"journal":{"name":"TARGETS","volume":"2 2","pages":"Pages 58-64"},"PeriodicalIF":0.0,"publicationDate":"2003-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1477-3627(03)02298-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90001919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}